News & Updates

GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024 byJairia Dela Cruz

Individuals with type 2 diabetes (T2D) treated in routine clinical care appear to fare better with glucagon-like peptide-1 receptor agonists (GLP-1RAs) than with dipeptidyl peptidase-4 inhibitors (DPP-4is), with GLP-1Ras being associated with lower rates of hyperkalemia and renin-angiotensin system inhibitor (RASi) medication discontinuation, as shown in an observational study.

GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024 byStephen Padilla

The incidence of cirrhosis and hepatocellular carcinoma (HCC) among veterans differs according to demographic and clinical characteristics, with the lowest rate seen among Asians, reports a study.

Multiple factors influence risks of cirrhosis, HCC in veterans with MAFLD
17 Aug 2024
Traditional CVD risk factors predict BP trajectories in adults
Traditional CVD risk factors predict BP trajectories in adults
13 Aug 2024

Many traditional risk factors for cardiovascular disease (CVD) show an association with unfavourable long-term blood pressure change (BPC) or BP trajectories in adults, suggests a China study.

Traditional CVD risk factors predict BP trajectories in adults
13 Aug 2024
Urinary peptides linked to hypertension
Urinary peptides linked to hypertension
13 Aug 2024

Several urinary peptides show a significant association with hypertension, with apparent “differential regulation of collagen-derived peptides,” a recent study has shown. In addition, peptides associated with vascular calcification and sodium regulation are also involved.

Urinary peptides linked to hypertension
13 Aug 2024